000 01227 a2200301 4500
005 20250518080445.0
264 0 _c20201111
008 202011s 0 0 eng d
022 _a1545-4304
024 7 _a10.1146/annurev-pharmtox-010919-023356
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSantoro, Bina
245 0 0 _aHyperpolarization-Activated Cyclic Nucleotide-Gated Channels as Drug Targets for Neurological Disorders.
_h[electronic resource]
260 _bAnnual review of pharmacology and toxicology
_c01 2020
300 _a109-131 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650 0 4 _aAnimals
650 0 4 _aDrug Design
650 0 4 _aHumans
650 0 4 _aHyperpolarization-Activated Cyclic Nucleotide-Gated Channels
_xchemistry
650 0 4 _aNervous System Diseases
_xdrug therapy
650 0 4 _aNeurons
_xmetabolism
650 0 4 _aProtein Isoforms
650 0 4 _aReceptors, Cytoplasmic and Nuclear
_xmetabolism
700 1 _aShah, Mala M
773 0 _tAnnual review of pharmacology and toxicology
_gvol. 60
_gp. 109-131
856 4 0 _uhttps://doi.org/10.1146/annurev-pharmtox-010919-023356
_zAvailable from publisher's website
999 _c30496610
_d30496610